Brief: Aligos Therapeutics Files Prospectus Related To Resale From Time To Time Of Up To 168.7 Million Shares Of Common Stock, By Selling Securityholders
17/11/2023 21:58
Nov 17 (Reuters) - Aligos Therapeutics Inc ALGS.O :
* ALIGOS THERAPEUTICS INC FILES PROSPECTUS RELATED TO RESALE
FROM
TIME TO TIME OF UP TO 168.7 MILLION SHARES OF COMMON STOCK, BY
SELLING SECURITYHOLDERS
Further company coverage: ALGS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aligos Therapeutics
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, Snowflake
Brief: Aligos Therapeutics Announces First Participant Dosed In The Phase 1 Study Of Its Potentially Best-In-Class Antisense Oligonucleotide Alg-170675 By Its Partner Amoytop In China
Aligos Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aligos Therapeutics Q2 net loss narrows on licensing revenue